Chris Gibson

Everything Chris Gibson said on any show that made the record, most notable first. Each card names its show and opens the statement there.

TOP FOUNDERS Insight

Gibson: Traditional life sciences investors value single assets over platforms

“So we are a platform company, and in our particular space, that's in life sciences, that's actually not the language that people speak in terms of value. They speak in terms of assets. And so that was one of the real challenges for us in terms of raising money…”

Chris Gibson Apr 17, 2017 ▶ 11:27 632: Recursion enzyme company raises $23M, launched in 2013 now 40 people with drugs ready for market with CEO Christopher Gibson

TOP FOUNDERS Disclosure

Gibson: Recursion partnered with Sanofi Genzyme to repurpose shelved drugs

“We've announced, for example, a partnership with Sanofi Genzyme, and in that particular case, we have drugs that, that they spent decades working on in many cases, and those drugs never ended up making it to patients, not because they're bad drugs, just becaus…”

Chris Gibson Apr 17, 2017 ▶ 2:44 632: Recursion enzyme company raises $23M, launched in 2013 now 40 people with drugs ready for market with CEO Christopher Gibson

TOP FOUNDERS Disclosure

Gibson: Recursion is eight months from clinical trials for CCM

“We also have an internal pipeline of drugs that we're developing ourselves one of those is just about eight months away from clinical trials now for a disease called cerebral cavernous malformation.”

Chris Gibson Apr 17, 2017 ▶ 4:20 632: Recursion enzyme company raises $23M, launched in 2013 now 40 people with drugs ready for market with CEO Christopher Gibson

TOP FOUNDERS Disclosure

Gibson: Recursion is negotiating eight-figure upfront biotech partnership deals

“And then there's partnerships we're negotiating now that are eight figures upfront.”

Chris Gibson Apr 17, 2017 ▶ 6:34 632: Recursion enzyme company raises $23M, launched in 2013 now 40 people with drugs ready for market with CEO Christopher Gibson

TOP FOUNDERS Assertion Supported

Gibson: Recursion raised $19M in equity and $5-6M in non-dilutive grants

“Yeah, we've raised about nineteen million dollars in, in equity financing, and then another five or six million in sort of non-dilutive funds from small business grants from the NIH, and then a number of private foundations as well.”

Chris Gibson Apr 17, 2017 ▶ 10:36 632: Recursion enzyme company raises $23M, launched in 2013 now 40 people with drugs ready for market with CEO Christopher Gibson

The other half of the tape: Chris Gibson's own voice is left out of every number here. Other people bring the name up 1 time in 1 episode across the shows. every mention, with the transcript →

Who brings them up most Nathan Latka 1

Every mention by year

One line per show, most statements first. The link opens Chris's full record on that show: the calibration, argument clarity, speaking style and every statement made there.

Show	Role there	Eps	Statements	Record
TOP FOUNDERSLEDGER	Operating Partner, Dimension Capital	1	5	100% 1/1	full record on Top Founders →